New Delhi: AIIMS New Delhi has completed India's first clinical trial of an indigenously tested brain stent for treating severe strokes, marking a milestone in the country's stroke care capabilities. The results, published this month in the Journal of NeuroInterventional Surgery, demonstrate that high-quality, affordable stroke treatment can be delivered within India.

The GRASSROOT trial evaluated the Supernova stent retriever, a device designed to remove blood clots in patients suffering from acute ischemic strokes caused by large vessel blockages. The multicentre trial enrolled 32 patients across eight stroke centres between August 2024 and June 2025, with the first patient recruited on August 26 last year.

Strong Safety and Efficacy Results

According to the published findings, doctor

See Full Page